AARC with input from North Carolina respiratory therapy leaders immediately began researching the situation and ultimately went to the Centers for Medicare and Medicaid Services (CMS) to address the issue from a nationwide standpoint.
CMS suggested that the AARC develop a Position Statement clarifying the profession’s stance on the delivery of respiratory medications and now that Statement has been approved by the AARC Board of Directors. Additionally, the position statement was sent to the Board of Medical Advisors of the AARC and received their endorsement.
Read more on the AARC website.
